BSEInsider Trading / SAST2d ago · 23 Sept 2026, 11:21 am

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

Krishna Institute of Medical Sciences Ltd · 543308

✦ AI SummaryPledge

Catalyst Trusteeship Limited has acquired 2,80,08,979 shares of Krishna Institute of Medical Sciences Ltd through pledge of equity shares by Bhaskara Rao Bollineni and Bollineni Seenaiah Naidu in favour of Catalyst Trusteeship Limited.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

3194457B_55E2_46B6_A0EE_8CD8AC39C00A_112150.pdf

pdf

Download →
View document text
3) KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED D.NO.1-8- SECUNDERABAD-3, ANDHRA PRADESH, Telangana, India -500003. Sub: Disclosure pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in relation to pledge of equity shares of KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED For Catalyst Trusteeship Limited AuthorisedSignatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: 22 September 2026 Part A Annexure Disclosures under Regulation 29(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part-A-Details of the Acquisition 1. Name of the Target Company (TC) KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED 2.Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture Concert (PAC) with the acquirer Trustee on behalf of Debentureholders 3.Whether the acquirer belongs to No. Promoter/Promoter group 4.Name(s) of the Stock Exchange(s) where the shares BSE Limited and National Stock Exchange of India of TC are Listed Limited 5.Details of the acquisition as follows Number % w.r.t. total % w.r.t. total share/voting diluted capital wherever share/voting applicable(*) capital of the TC (**) Before the acquisition under consideration, holding of acquirer along with PACs of: a) Shares carrying voting rights - - - b) Shares in the nature of encumbrance - - - (pledge/lien/non-disposal undertaking/others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) - - - Details of acquisition a) Shares carrying voting rights acquired - - - b) VRs acquired otherwise than by equity shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying category) acquired d) Shares in nature of encumbrance (pledge/lien 2,80,08,979 6.66 6.66 /non-disposal undertaking/others) e) Total (a+b+c+d) 2,80,08,979 6.66 6.66 After the acquisition, holding of acquirer along with PACs of: a) Shares carrying voting rights - - - b) VRs otherwise than by equity shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition d) Shares in nature of encumbrance 2,80,08,979 6.66 6.66 (pledge/lien/non-disposal undertaking/others) e) Total (a+b+c+d) 2,80,08,979 6.66 6.66 6.Mode of acquisition (e.g. open market / public By way of pledge of equity shares of the Target issue / rights issue / preferential allotment / inter-se Company in favour of Catalyst Trusteeship Limited transfer/encumbrance, etc.) 7.Salient features of the securities acquired including Pledge over 2,80,08,979 equity shares of the Target time till redemption, ratio at which it can be Company by Bhaskara Rao Bollineni and Bollineni converted into equity shares, etc. Seenaiah Naidu in favour of Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders. 8.Date of acquisition of/ date of receipt of intimation 18-Sep-2026 of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC. Rs. 84,00,12,968 (42,00,06,484 Equity shares having 9.Equity share capital / total voting capital of the TC face value of Rs 2 each) before the said acquisition Rs. 84,00,12,968 (42,00,06,484 Equity shares having 10.Equity share capital/ total voting capital of the TC face value of Rs 2 each) after the said acquisition Rs. 84,00,12,968 (42,00,06,484 Equity shares having 11.Total diluted share/voting capital of the TC after face value of Rs 2 each) the said acquisition Signature of the acquirer: For Catalyst Trusteeship Limited AuthorisedSignatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: 22 September 2026